Complete Story
 

Pfizer’s Biosimilar RETACRIT® (epoetin alfa-epbx) Approved by

 

Click here to learn more about the approval of Pfizer’s ESA Biosimilar.

 

Printer-Friendly Version


Corporate Members view all sponsors